Nuclera Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 60
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $58.5M
Latest Deal Amount
  • Investors
  • 10

Nuclera General Information

Description

Operator of a DNA synthesis company intended to create a DNA synthesis platform capable of producing genes and proteins on-demand. The company's services mainly focus on engineered terminal deoxynucleotidyl transferases and its enzymes are proven to quantitatively incorporate a wide variety of reversibly terminating nucleoside triphosphates of all four nucleobases, enabling users to conduct the production of gene and genome libraries.

Contact Information

Website
www.nuclera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 137 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0GD
  • England, United Kingdom

Nuclera Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuclera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 02-Feb-2022 $58.5M 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series A) 24-Mar-2020 00.000 000.00 000.00 Completed Generating Revenue
7. Early Stage VC (Series A) 13-Dec-2018 00.000 00.000 000.00 Completed Generating Revenue
6. Accelerator/Incubator 22-Feb-2017 00000 Completed Startup
5. Grant 01-Jul-2015 00000 00000 Completed Startup
4. Grant 01-Jul-2014 000.00 00000 Completed Startup
3. Grant 01-May-2014 00000 00000 Completed Startup
2. Accelerator/Incubator $837K Completed Startup
1. Seed Round 01-May-2014 $837K $837K 00.000 Completed Startup
To view Nuclera’s complete valuation and funding history, request access »

Nuclera Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series B 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 39,499 $0.000136 $5.4 $5.4 1x $5.4 0.59%
Ordinary 250,000 $0.000136 $2.71 $2.71 1x $2.71 3.71%
To view Nuclera’s complete cap table history, request access »

Nuclera Patents

  • 53

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 12

    Pending

  • 000

    Expiring in next 12 mo

Nuclera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202005043-D0 C5-modified thymidines Ceased 06-Apr-2020 000000000
US-20210256920-A1 Latched transistor driving for high frequency ac driving of ewod arrays Pending 19-Feb-2020 0000000000
US-20210256919-A1 Adaptive gate driving for high frequency ac driving of ewod arrays Pending 18-Feb-2020 00000000
US-20210231606-A1 Method for degassing liquid droplets by electrical actuation at higher temperatures Pending 27-Jan-2020 000000000000
US-20210220830-A1 Spatially variable dielectric layers for digital microfluidics Pending 17-Jan-2020 B01L3/502792
To view Nuclera’s complete patent history, request access »

Nuclera Executive Team (3)

Name Title Board Seat Contact Info
Michael Chen Ph.D Co-Founder, Chief Executive Officer & Board Member
Jiahao Huang Ph.D Co-Founder, Chief Financial Officer & Board Member
Gordon McInroy Ph.D Co-Founder, Chief Technology Officer & Board Member
To view Nuclera’s complete executive team members history, request access »

Nuclera Board Members (8)

Name Representing Role Since
Barnaby Martin RT Partners Board Member 000 0000
Gordon McInroy Ph.D Nuclera Co-Founder, Chief Technology Officer & Board Member 000 0000
Jiahao Huang Ph.D Nuclera Co-Founder, Chief Financial Officer & Board Member 000 0000
Joseph Keegan Nuclera Board Member 000 0000
Michael Chen Ph.D Nuclera Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Nuclera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuclera Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amadeus Capital Partners Venture Capital Minority 000 0000 000000 0
British Business Bank Business Development Company Minority 000 0000 000000 0
E Ink Corporation Minority 000 0000 000000 0
Future Planet Capital Growth/Expansion Minority 000 0000 000000 0
GK Goh Holdings Corporation Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Nuclera Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0 000 (000000 12-May-2021 000000000 000.00 Buildings and Property 0000000 0
To view Nuclera’s complete investments history, request access »

Ready to get started?

Request a free trial